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The mechanisms of action of thyroid hormone (TH), characterized by multiple physiological activities, proposed over the last
80 years are a reﬂection of the progression of our knowledge about eukaryotic signalling processes. The cumulative knowledge
gained raises the question as to what is so special about the action of this hormone. The discovery in the 1980s that TH receptors
belong to the family of nuclear transcription factors that regulate the expression of hormonal target genes was an important
milestone. TH receptors are highly organized within the chromatin structure, which itself is modiﬁed by several chromosomal and
nonchromosomal factors, in the presence and absence of the hormone. Recently, some investigators have suggested that TH acts
via both genomic and nongenomic mechanisms and introduced the concept of networking within cellular complexes. While one
cannot as yet precisely describe the mechanism of thyroid hormone action, I will attempt here to point out the present thinking
and future directions to achieve this goal in the light of the historical background.
1.Introduction
Even before L-thyroxine (3,3 ,5,5 -tetraiodothyronie or T4)
was identiﬁed by Kendall in 1919 as the active thyroid
hormone in the thyroid gland, and later synthesized by
Harington in 1926 [1], physiologists and biochemists had
already proposed in the ﬁrst two decades of the twentieth
century several mechanisms of actions of the hormone (see
[2]). Although the hormone was known to be endowed with
multiple metabolic and developmental activities, most stud-
ies at ﬁrst focused on the calorigenic action of the hormone,
largely because of the clinical association between basal
metabolic rate (BMR) and thyroid gland morphology and
activity. The dramatic role of thyroid hormone in amphibian
metamorphosis, demonstrated by Gudermatsch in 1911,
was largely ignored for twenty years by those interested in
explaining the biochemical mechanisms underlying thyroid
hormone action.
It took nearly 35 years after thyroxine that 3,3 ,5-triiodo-
L-thyronine (T3) was identiﬁed, almost simultaneously as
a constituent of thyroglobulin in the thyroid gland and in
human blood in the laboratories of Roche in Paris and Pitt-
Rivers in London. Not long after that, several laboratories
conﬁrmed that T3 is biologically more active than T4 in
several physiological assays, such as BMR, amphibian meta-
morphosis, lipid metabolism, and pituitary function [2, 3].
A larger part of T3 in the blood and peripheral tissues of
most vertebrates is derived from the partial deiodination of
T4 than was produced in the thyroid gland. This conversion
has given rise to the commonly held view that T3 is
the biologically active thyroid hormone while T4 is the
prohormone, the enzyme responsible for the conversion,
one of the deiodinases which remove I atoms from the
inner and outer rings of T4 and T3. The deiodinases are
considered to be important in the dynamics of TH activity
[4]. For the purposes of this review, I shall consider T3
as the biologically active thyroid hormone and T4 as the
pro-hormone, while the term TH will include any of their
derivatives or conjugates with biological activity.
A major advance in our understanding of the bio-
chemical and molecular basis of the action of TH was the
identiﬁcation, cloning, and characterization of its receptors
(TRs)in1986inthelaboratoriesofVennstr¨ om[5]andE vans
[6].Thesereceptorsaremembersofalargemultigenicfamily
of transcription factors which are activated by hormonal or
other signalling molecules. TRs are integral chromosomal
proteins whose structure and chemical nature is modiﬁed by
TH. The liganded receptor is such that they would modify2 Journal of Thyroid Research
Table 1: Multiplicity of physiological and biochemical actions of thyroid hormone.
Growth and developmental actions Metabolic actions
Rate of postnatal growth of many mammalian and avian tissues Regulation of basal metabolic rate in endotherms
Functional and biochemical maturation of fetal brain and bone
Movement of water and Na+ ions across cell
membranes
Calcium and phosphorus metabolism
Morphogenesis, gene switching, and cell death in amphibian larval
metamorphosis
Regulation of metabolism of cholesterol and other
lipids
Control of molting in birds Nitrogen (urea, creatine) metabolism
Regulation of synthesis of mitochondrial respiratory enzymes and
membranes
Control of oxidative phosphorylation and energy
metabolism
the interaction between the receptor and its target genes,
leading, directly or indirectly, to the physiological action
of the hormone [7]. Much progress has been made in the
last 20 years in enhancing our knowledge of chromosomal
or chromatin structure, so that it is not surprising that a
substantial amount has been learnt about the possible ways
in which the structural and biochemical modiﬁcations of
chromatin would modulate the action of thyroid hormone
[8]. These advances have most recently led to exploring the
processes of networking within and between cells and wider
questions of systems biology for further exploration of the
search for mechanism of hormone action [9, 10].
Thispaperisabriefreviewofsomehistoricalandcurrent
thinking and work relating to the mechanism of action of
thyroid hormone covering the period of the last 80–90 years
and gives a largely, but not uniquely, personal point of view
of the author. It is not meant to be a comprehensive review
of thyroid hormone action. If any of the readers’ work or
ideas are not cited below, it is not the author’s intention to
diminish the importance of their contributions to this ﬁeld
of research.
2. MultipleEffects but Unique
Mechanismof Action?
Can one explain the multiple biological eﬀects of thyroid
hormone with a unique mechanism of action? First, let
us consider the multiplicity of actions. Towards the end
of the 19th century, physicians and surgeons in England,
France, and Switzerland established the link between the
thyroid gland and iodine deﬁciency disorders such as goitre,
cretinism,andmyxoedemainman.Bytheearly20thcentury,
removal of the gland in experimental animals and grafting
it back to reverse the eﬀects of thyroidectomy corroborated
the beneﬁcial eﬀects of administering ovine, bovine, and
porcine thyroid powder or extracts for the treatment of
patients suﬀering from myxoedema, cretinism and growth
retardation in children, or other consequences of thyroid
deﬁciency.ThechanceobservationinNaplesbyGudernatsch
that feeding pieces or extracts of mammalian thyroid
gland to frog tadpoles precociously induced metamorphosis
emphasized the important role of thyroid hormone in
regulating postembryonic growth and development in all
vertebrates [11]. The establishment of L-thyroxine and
triiodo-L-thyronine as the biologically active principles in
the thyroid and peripheral tissues and the availability of
synthetic T4 and T3, and many of their biologically active
and inactive homologues, made it possible to establish, both
qualitatively and quantitatively, the characteristics of the
multiple hormonal activities.
In Table 1 are listed the major physiological actions of
thyroid hormone, which can be loosely subdivided into
two groups: (a) those that regulate metabolic functions
and (b) those that control growth and development. It is
immediately obvious that the biological responses to the
hormone vary according to species, tissue, and develop-
mental stage. Generally, the metabolic responses are most
visible in endotherms, often manifested as basal metabolic
rate (BMR), water retention lipid metabolism, and so
forth. The hormonal eﬀects on growth and development
are particularly evident in ectotherms, and less during the
postembryonic or perinatal period in mammals and other
warm-blooded vertebrates. It should be emphasized that
separation of the physiological and biochemical actions of
TH into two categories, as in Table 1, does not imply a
sharp boundary between the two, and that there can be some
overlap determined by the variables mentioned above.
An even more striking example of the multiple responses
to TH is seen when comparing tissue-speciﬁc responses to
the hormone during amphibian metamorphosis, illustrated
in Table 2. The process can be precociously induced by
the administration of exogenous TH to immature tadpoles,
which conﬁrms the fact that the developmental programme
is well in place before the larval thyroid gland is fully
developed and can begin to secrete the hormone [12].
An important feature of the multiplicity of actions that
emerges from Table 2 is that no two tissues or groups of
cells exhibit the same hormonal responses, which range from
de novo morphogenesis, as for limb and lung development,
functional reprogramming, as for the brain, liver, and eye,
total or partial tissue loss of tissue, as seen for the tadpole tail
and gills. Similar processes are discernible, albeit less clearly
and more attenuated, in other vertebrates and mammals
during the perinatal period. Indeed, tissue-speciﬁc gene
switching is central to hormonal signalling, not only as
regards TH but also many steroid and protein hormones that
regulate growth and development in general.
Early investigators were intrigued by how the relatively
simple, but quite unique, molecule of a hormone as THJournal of Thyroid Research 3
Table 2: Morphological and biochemical responses to thyroid hormone during amphibian metamorphosis.
Tissue
Response
Morphological Biochemical
Brain Restructuring, axon guidance, axon
g r o w t h ,c e l lp r o l i f e r a t i o n ,a n dd e a t h
Cell division, apoptosis, and new
protein synthesis
Liver Restructuring, functional
diﬀerentiation
Induction of urea cycle enzymes and
albumin; larval to adult haemoglobin
gene switching
Eye Repositioning; new retinal neurones
and connections; lens structure
Visual pigment transformation
(porphyropsin → rhodopsin); β-
crystallin induction
Skin
Restructuring; skin granular gland
formation; keratinization and
hardening; apoptosis
Induction of collagen, 63kDa (adult)
keratin and magainin; induction of
collagenase
Limb bud, lung Do novo formation of bone, skin,
muscle, nerves, and so forth.
Cell proliferation and diﬀerentiation;
chondrogenesis
Tail, gills Complete regression
Programmed cell death induction and
activation of lytic enzymes
(collagenase, nucleases, phosphatases,
and matrix metalloproteinases);
lysosome proliferation
Pancreas,
Intestine Major tissue restructuring
Reprogramming of phenotype,
induction of proteases, fatty acid
binding protein, and stromelysin-3
Immune system Redistribution of cell populations
Altered immune system and
appearance of new immunocompetent
components
Muscle Growth and diﬀerentiation; apoptosis Induction of myosin heavy chain
See [11, 34]f o rd e t a i l s .
orchestrated such diverse eﬀects. Is there a single mech-
anism of action that governs this diversity of responses
or is each manifestation of hormonal activity the result
of a diﬀerent mechanism? At ﬁrst, physiologists and bio-
chemists attempted to explain the mechanisms underlying
their actions as being common to all hormones, but as
increasing numbers of hormones became available as pure
substances, and as the biochemical and physiological end-
points were better characterized, there was a move away
from a generic mechanism of hormone action. Furthermore,
as our understanding of complex whole-body physiological
processes progressed from biochemical mechanisms, such as
enzymology,toreceptoranalysis,tostructuralcellbiology,to
geneticnetworks,sodidtheexplanationsforhormoneaction
continue to evolve.
3. EarlyStudies on the Mechanismof
Action of TH
Table 3 summarizes the progression of some major ideas
concerning the mechanism of thyroid hormone action
following the synthesis of thyroxine, that is, over the ﬁfty
years until around 1980. By the early 1930s, it was thought,
the activation or inhibition of a given enzyme resulting from
the interaction between the hormone and the enzyme could
explain the physiological action of the hormone [2]. For
example, the stimulation by T4 or T3 of oxygen consumption
by isolated tissues or that of BMR in vivo was explained
on the basis of a direct interaction between the hormone
and some dehydrogenases, the phenomenon often termed
allosteric or conformational changes in the enzyme. These
direct hormone-enzyme interaction models were eventually
discarded because of serious methodological discrepancies,
for example, the concentrations of hormone used in vitro
would be several orders of magnitude higher than it would
ever occur in vivo, or that biologically inactive analogues of
the hormone would be often more active than the natural
hormone in direct interactions.
The realization that the regulation of biochemical func-
tions in vivo had to be considered in the context of complex
cellular structures led to models which took into account
the structural organization of physiological activities. Major
advances, both technical and conceptual, in the 1950s and
early 1960s introduced the idea that the cell membrane,
the mitochondrion, the protein synthesizing machinery, and
the cell nucleus constituted valid targets for hormones,
vitamins, drugs, and other biologically active molecules [13].
Although already in the 1940s Levine had demonstrated that
insulin controlled sugar metabolism by interacting with its
transport machinery residing in the cell membrane, it was
the discovery of cyclic AMP (cAMP) by Sutherland and
Rall in 1956 as a “second messenger” of adrenaline and
glucagon followed by the equally important discovery that
adenylyl cyclase was located in the plasma membrane ﬁrmly4 Journal of Thyroid Research
Table 3: Milestones in the search for mechanism of thyroid
hormone action.
Year/Period Milestone
1905 Starling introduces the word hormone and the
concept of chemical messengers
1911 Mammalian thyroid extracts shown to induce
amphibian metamorphosis
1919 Thyroxine and cortisone extracted and chemically
characterized by Kendall
1920–1935 Eﬀects of thyroid hormone on tissue and whole
body respiration and metabolic functions
1925–45 Isolation and characterization of pituitary protein
hormones
1935–50 Hormone-enzyme interactions thought to explain
hormone action
1941–55 Insulin and other hormones shown to regulate
transport processes
1955-62 Thyroxine thought to act by uncoupling oxidative
phosphorylation
1956 Discovery of cyclic AMP by Sutherland and the
concept of “second messenger”
1960
Ecdysteroids induce chromosomal puﬃng during
insect development—ﬁrst indication of hormone
action at the nucleus
1962 Oestradiol shown to bind to nuclear proteins. First,
indication of nuclear receptors
1962–66
Steroid and thyroid hormones and retinoids
selectively regulate protein synthesis and
transcription
1975–85
Protein hormone receptors located in cell
membranes identiﬁed as homologues of c-erbB
oncogene; protein phosphorylation cascades
identiﬁed
1979–89
Steroid/thyroid/retinoid receptors cloned as a large
family of c-erbA-related transcription factors
interacting with target genes and modifying
chromatin structure
1990s
Crystal structures for many hormone receptors and
partners. Transgenesis and mutagenesis of
receptors in vivo
1996 Coactivators and corepressors modulate gene
expression by TR and other nuclear receptors
1998
Phosphorylation, acetylation, and methylation of
TR and other nuclear receptors, histones, and
chromosomal proteins
2002–2010
Convergence of hormonal signals via membrane
and nuclear receptors. Emergence of concepts of
systems biology, bioinformatics and gene, and
metabolic networking applicable to hormone
action
established the view that the cell membrane is a major site of
action for hormones [14].
At almost the same time as cyclic AMP was discovered,
Knox demonstrated that glucocorticoids regulate hepatic
metabolism by selectively enhancing the synthesis of the
enzyme tyrosine aminotransferase [15]. New methods to
study cell-free protein synthesis and the availability of spe-
ciﬁc transcription inhibitors allowed a more precise analysis
of how growth and developmental hormones inﬂuenced
protein synthesis in their respective target cells. The resulting
observations that all steroid and thyroid hormones admin-
istered in vivo aﬀect the protein synthesizing machinery
in vitro soon shifted the focus on transcriptional control
[16]. In the mid-1960s, several investigators were able to
reproduce the transcriptional eﬀects of steroid and thyroid
hormones in cell-free transcription systems using isolated
nuclei and nuclear extracts from target tissues following
hormonal administration in vivo. Kinetics of labelling of
nuclear RNA further revealed that all steroid and thyroid
hormones strongly inﬂuence the formation and turnover of
messenger RNA.
In1961, Jensenhadmade theimportant observation that
highly radioactive estradiol very rapidly (within minutes)
accumulated in the nucleus of its target tissues (see [17]).
This and subsequent investigations laid the foundation of
the concept of nuclear receptors for steroid and thyroid
hormones, retinoids, vitamin D3, and so forth. A decade
later, Oppenheimer carried out a similar investigation on
the selective nuclear localisation of radioactive T3 in rat
liver [18]. The main signiﬁcance of this ﬁnding is that the
accumulation of the hormone anticipated by several hours
the stimulation of transcription, translation, and cellular
respiratory responses to this hormone in other cellular
organelles of the same tissue under identical conditions. This
is schematically illustrated in Figure 1. What is particularly
important in this kind of time-course representation of
diﬀerent cellular responses is that inhibition of transcription
abolishes the subsequent, diﬀerent responses and biological
activities of thyroid hormone in diﬀerent mammalian and
amphibian biochemical functions, such as protein synthesis,
respiration, morphogenesis, and cell death [3, 19]. Although
the binding of TH and steroid hormones to target cell
nuclei exhibited many of the functional characteristics of
receptors, one had to wait till the technologies of gene
cloninghadbeenwellestablishedtomakethenextimportant
step of establishing the nature of nuclear receptors, their
organization in cellular structures, and their functional
signiﬁcance.
4. LaterStudies on the Mechanismof
Action of TH
The ﬁrst indication that hormonal signals regulate transcrip-
tion was, however, provided by gene puﬃng in polytenic
chromosomes in larval salivary glands of insects, such as
Drosophila and Chironomus, during their metamorphosis
induced by the molting hormone ecdysone [20, 21]. These
puﬀs, which contain newly synthesised RNA from sequential
activation of speciﬁc genes, can be precociously induced
by incubating the target cells with ecdysteroids. Kinetics of
labelling of nuclear RNA revealed that all steroid and thyroid
hormones strongly inﬂuenced the formation and turnover
of messenger RNA. In the mid-1960s, several investigators
wereabletoreproducetheeﬀectsof invivo administration ofJournal of Thyroid Research 5
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Figure 1:Anidealizedrepresentationofthetimecourseofresponse
of some activities of nuclei, mitochondria, and microsomes from
livers of thyroidectomized rats after a single injection of 20μg
T3/100g. body wt. The stimulatory eﬀects are expressed as %
increase in speciﬁc activity in the diﬀerent subcellular fractions
from T3-injected animals over control animals. The main features
are the following: (a) mitochondrial respiration (here expressed
as cytochrome oxidase activity) reached a peak after amino acid
incorporation into protein by microsomes and mitochondria; (b)
the increase in protein synthetic capacity of the two organelles
was coupled, following a relatively long lag period after hormone
administration; (c) nuclear RNA polymerase activity was enhanced
several hours before cytoplasmic protein synthesis and BMR. The
time course of nuclear accumulation of T3 (×···×;[ 18]) is
superimposed on that of the hormonal eﬀects on mitochondrial,
transcriptional, and protein synthetic activities (Data assembled
from [22–24]).
the hormone in cell-free transcription systems using isolated
nuclei and nuclear extracts from target tissues of steroids and
TH [16].
When Jensen and colleagues tracked the sex hormone
oestradiol-17β of high speciﬁc radioactivity to female acces-
sory sexual tissues, such as uterus and vagina, it was found
to accumulate in the nucleus as a complex with a protein
which fulﬁlled the criteria for a receptor [17, 25]. Following
the work from the laboratories of Chambon, Evans, and
Vennstrom in the 1980s on the cloning of ER, TR, and GR,
morethan35nuclearreceptorshavebeencloned,sequenced,
andobtainedaspurerecombinantproteins,includingseveral
termed as “orphan” receptors, that is, whose ligands remain
unknown. All nuclear receptors, which are products of the
oncogene v-erbA, function as ligand-activated zinc-ﬁnger
transcription factors with a modular structure comprising
six domains [7, 26–28]. Nuclear hormone receptors can
be subdivided into two groups, according to whether they
form cytoplasmic complexes with hsp90 and are active as
monomer and homodimer or as heterodimers. All vertebrate
steroid hormone receptors belong to the ﬁrst category, while
the liganded receptors for retinoic acid, TR, vitamin D3
(VDR), and peroxisome proliferator (PPAR) function as
heterodimerswithRXR,the9-cis-retinoicacidreceptor.This
groupofreceptorsexistasmultipleisoforms,themultiplicity
residing in the N-terminus of the receptor, which is a well-
established characteristic of TRs present as TRα and TRβ,
often exhibiting quite distinct functions.
An interesting question arises as to how the high degree
oftargetgenespeciﬁcityforagivenhormoneanditsreceptor
is achieved within the above group of nuclear receptors
comprising TR. The answer lies in the highly precise spacing
of nucleotide repeats in the hormone response element
(HRE) of the promoter of the target gene and the DNA-
binding domain (DBD) of the receptor which recognises it.
Interestingly, the HREs of the nonsteroid receptors, that is,
TR,RAR,RXR,VDR,andPPAR,allsharethesameAGGTCA
hexad but are organised as direct repeats (DRs) separated by
one to ﬁve nucleotides. This arrangement of HREs explains
the ﬁne discrimination of target genes by the heterodimers
formed by each of these receptors with RXR and which
confers an extraordinary hormonal speciﬁcity. It is a most
remarkable biochemical example of selective transcriptional
regulation, conﬁrmed for TR by NMR spectroscopy and X-
raycrystalstructureanalysis[29].Anotherinterestingfeature
of TRs is that in the absence of its ligand (TH) it acts
as a strong inhibitor of transcription, a property that is
reversed upon the addition of TH [30]. In fact, Roeder and
his colleagues have exploited this unique characteristic of
TR to dissect biochemically the individual steps involved in
eukaryotic gene transcription. An ever-increasing number of
nonreceptorproteinsarenowknowntointeractwithnuclear
receptors and transcription factors, and that these complexes
may function synergistically or in a mutually antagonistic
manner [16]. For example, large protein molecules termed
CBP (CREB binding protein) and p300 are thought to form
bridges between nuclear hormone receptors, including TR,
and other transcription factors. This conclusion was arrived
at by the unexpected observation that nuclear receptors
inhibit the activity of the nonreceptor transcription factor
AP-1 by competing for limited amounts of CBP/p300
normally present in cells. Other important elements of the
complex are the p160 nuclear receptor co-activator and
the 270kDa nuclear receptor corepressor (N-CoR), which
have been puriﬁed and their functions tested. Evans and
collaborators undertook a structural and thermodynamic
analysis of the interaction domains of CBP and the p160
coactivators of TR and RAR to elucidate the assembly
of the multiprotein activation complex. They describe a
mechanism of mutual synergistic folding whereby the co-
activators recruit CBP/p300 to facilitate the transmission of
the hormonal signal to the transcriptional machinery [29].
Indeed, these examples of protein-protein interactions may
just be the tip of an iceberg, and future studies on how TR
function can be modiﬁed by other nuclear and extranuclear
entities may turn out to be quite rewarding.6 Journal of Thyroid Research
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Figure 2: A representation by Wolﬀe[ 8] of how a ligand-activated nuclear receptor could modify the higher-order structure of chromatin.
ThepackagingofDNAintochromatinisvisualizedinthreetranscriptionallyactivestates:normal,repressive,andactive.Inthisexample,the
regionofchromatinchosencontainsthethyroidhormonereceptor(TR)/RXRheterodimer,withorwithoutitsligandtriiodothyronine(T3),
bound to the thyroid responsive element (TRE) in the target gene. In normal chromatin, histone acetylation is at its basal level and so is the
transcriptional activity. In the absence of T3 (as during early stages of development), chromatin exists in its condensed and transcriptionally
repressive form whereby the histones are in a largely deacetylated state with no transcription of the TR’s target gene. In the presence of
T3, the chromatin is now active with elevated levels of histone acetylation and transcription. The other components are proteins that form
“corepressor” and “coactivator” complexes with complexes with the TR/RXR receptor heterodimer. For more details, see [8].Journal of Thyroid Research 7
The signiﬁcance of protein-protein interactions, in the
context of regulation of transcription by TH via TR,
h a sb e e ne x t e n d e dt oc e l ls t r u c t u r eb yW o l ﬀe[ 8]. As
described schematically in Figure 2, changes in chromatin
structure, induced by histone modiﬁcations, in the presence
and absence of T3 are thought to underly the hormonal
regulation of expression of speciﬁc genes (details in legand
to Figure 2).
5. Expression of TR Genes
The expression of the two TH receptor genes TRα and
TRβ in Xenopus tadpoles is under developmental control
[31]. Very small amounts of both TR transcripts can be
detectedinunfertilizedeggsandearlyembryos.Asubstantial
increase, particularly of TRα m R N A ,o c c u r sa ta r o u n ds t a g e
44, which, quite signiﬁcantly, is when the Xenopus tadpole
ﬁrst exhibits competence to respond to exogenous thyroid
hormone. At this stage of development, several tissues which
are programmed to undergo major changes later during
metamorphosis show high concentrations of TR mRNA,
such as brain, liver, limb buds, small intestine, and tail.
After stage 54 and until the completion of metamorphosis,
there is good correlation between the accumulation of TR
transcripts and the circulating level of thyroid hormone in
Xenopus tadpoles [32, 33] .T h er e l a t i v ea m o u n t so fT R α and
β mRNAs vary according to the tissue of the tadpole and also
according to the progression of metamorphosis. There is a
possibility, not yet ﬁrmly proven, that the multiplicity of TH
actions may in part arise from the two TR isoforms acting on
diﬀerent cellular or biochemical targets. Several studies from
the laboratories of Brown, Shi, and Tata have established
that administration of exogenous T3 to premetamorphic
stages of Xenopus tadpoles causes a substantial induction
of TR mRNA [12, 34, 35] .T h es a m ep h e n o m e n o no f
“autoinduction” of TR mRNA is observed for Xenopus
tadpole tails following exposure to TH in vivo and in organ
culture, a tissue programmed not for further morphogenesis
but for cell death and total regression [19]. In all these
studies, the extent of “autoinduction” is more marked for
TRβ mRNA than for TRα. Also, the upregulation of TRβ
mRNA can be seen as early as 4h after the exposure of these
premetamorphic tadpoles to exogenous T3, which is among
the most rapid biochemical responses of Xenopus tadpoles to
the hormone. The exact period preceding the autoinduction
of TRβ receptor can vary according to the experimental
conditions in diﬀerent laboratories and can vary according
to the stage of development of the tadpole or whether one
adds the hormone to the whole organism, isolated tissues,
or cell cultures. There is also the possibility that some other
biochemical response may occur before the upregulation
of the receptor. It has been suggested that such an earlier
responsive element, as for example BTEB1, may be involved
intheautoinductionoftheTHreceptor[36].Nevertheless,it
is important to consider in this context that TRβ is a direct-
response gene, namely, that its upregulation occurs in the
absenceofproteinsynthesisandthatthepromoterinitsgene
comprises a fully responsive “thyroid-responsive element”
[34, 35].
What is the likely mechanism of autoinduction of TRs?
The most simple mechanism to explain the phenomenon
of auto-regulation would be a direct interaction between
TR proteins and the promoters of the genes encoding
them [34]. It is signiﬁcant, as already mentioned, that the
promoter of the Xenopus TRβ gene has two TREs of the
more common DR+4 (direct repeat +4) type, and that
transfection of Xenopus XTC-2 and XL-2 cells, which express
both TRα and β overexpression of unliganded TRα,a n dβ
in these Xenopus cell lines caused a substantial suppression
of basal transcriptional activity. Under the conditions of
transcriptional suppression, the addition of T3 to Xenopus
cells, cotransfected with the full-length TRβ promoter, pro-
duces up to 20-fold enhancement of TR gene transcription.
Furthermore, these studies have shown that TR-RXR het-
erodimers, which are the natural form of functional TRs, but
not TR monomers or homodimers, speciﬁcally interact with
the DR+4 TREs of TRβ gene promoter [37]. These studies
strongly support the idea of a direct interaction between
the thyroid hormone receptor and the promoter of its own
gene as the most likely mechanism underlying Xenopus TR
“autoinduction.” An indirect approach to understanding
the signiﬁcance of receptor autoinduction would be to
look for an intimate association between TR upregulation
and the expression of a TH target gene. One such study
involved the simultaneous measurement of the expression
in premetamorphic Xenopus tadpoles of TRβ and Xenopus
63kDa keratin gene, which is only induced by TH during
metamorphosis [38]. In stage 52 Xenopus tadpoles (which
is before they show signs of metamorphosis), T3 strongly
induced simultaneously the accumulation of TRβ transcripts
tadpoles de novo transcription of the adult keratin gene. The
same was true if TR upregulation by T3 was inhibited [38].
While such experiments do not establish a direct cause-eﬀect
relationship, they strongly suggest the intimate relationship
between autoinduction of TR and the activation of the
hormone’s target genes.
Of wider signiﬁcance, the phenomenon of autoinduction
is not restricted to TR upregulated by TH during amphibian
metamorphosis but is also seen with the expression of other
nuclear receptors, such as those for steroids and retinoids
[16, 21, 39]. A model has been proposed, whereby upregu-
lation of a given receptor is a prerequisite for the sequential
activation of its target genes that specify the hormone’s
biological action [11]. It predicts a double threshold of
receptor numbers, the ﬁrst, or lower level, which would be
essential and suﬃcient for the autoinduction of the receptor
and the second, higher threshold for the activation of target
genes with which the hormone-receptor complex interacts.
It also implies that the gene encoding a given receptor
is constitutively expressed to produce a very low level of
functional receptor in the target tissue at very early stages
of development, which indeed is the case for most growth
and developmental hormones and growth factors. One way
of validating this model would be to measure the relative
aﬃnities of interaction between the DNA-binding domain
or hormone-responsive elements in the promoters of the
receptor and target genes (which specify the phenotype of
biological action of the hormone).8 Journal of Thyroid Research
6. Singleor MultipleReceptors?
For nearly ﬁfty years until the 1980s, most explanations for
the mechanism of action of thyroid hormone were based
on a direct interaction of the hormone with individual
enzymes, membrane, and other cellular preparations with
ligand-binding properties, that is, nongenomic mechanisms
([2]; see Table 3). But the mid-1980s saw a sea change in
our thinking about the mechanism of action, not only of
TH, but also of all steroid hormones, retinoic acid, and
many nonsteroidal signalling molecules, with the discovery
ofnuclearreceptors,thatis,signalsactingviagenomicmech-
anisms[7,16,26,27].Thepowerfultoolsofgenecloningand
sequencing and cell transfection have helped place these later
genomicstudiesonaﬁrmerbiochemicalbase.Morerecently,
however, several investigators have reinvoked the possibility
that TH as well as steroid hormones and other signalling
moleculesactingvianuclearreceptorsalsoexertnongenomic
actions through extranuclear sites. The latter is particularly
relevant to those that involve rapid responses to the same
signal acting relatively slowly via genomic mechanisms (see,
e.g., [40–43]). This, in turn, raises the wider question
for all hormonal and nonhormonal signals as to whether
they operate through the same receptor, perhaps located
in diﬀerent cellular compartments, or whether the diﬀerent
genomic and nongenomic responses are the outcome of
interactions with diﬀerent receptors, irrespective of their
locations. While, unlike nuclear receptors, we still await
the isolation and precise information on the structure of
“nongenomic” receptors, it is of some interest to consider
some of the possible situations arising out of whether the
multiplicity of responses to a given hormone arise from
its interaction with a unique or multiple receptors, as
considered below.
As already shown in Table 1, thyroid hormone exerts
a wide range of actions in diﬀerent tissues and organs
(e.g., control of metamorphosis in amphibians and basal
metabolic rate in mammals). The same is true of signalling
molecules. Furthermore, almost all membrane and nuclear
hormone receptors are highly conserved as cellular homo-
logues of the oncogenes c-erbBa n dc - erbA, respectively,
which explains why several hormones can functionally
interact with their receptors in a wide range of phyla.
For example, analogous domains of the receptors of insect
hormone ecdysone and the vertebrate thyroid hormone
can be swapped to activate transcription in insect and
mammalian cells in a reciprocal fashion (see [44]). One is
thus faced with the question as to how, if both the hormonal
signal and its receptor are conserved through evolution, their
physiological actions are not. It underlines the importance of
an understanding of the postreceptor “Black Box” in order
to move further down the pathway in the search for the
mechanism of multiple actions of a given hormone.
To further consider the fact that hormone receptors
are evolutionarily conserved, but that their downstream
responses are not, three hypothetical, oversimpliﬁed, models
are presented in Figure 3. First, If one accepts that there
is a unique receptor for thyroid hormone in a given cell
(model 1), is it possible at some point along the chain of
postreceptor downstream responses that there is a point
where chains of events diverge, such that it could explain the
multiplicity of the physiological actions of the hormone, as
shown in Table 1? This possibility of divergence has led some
investigators to look for drugs to selectively enhance or block
some TH actions of, as has been implicit in the blocking
of cardiac eﬀects, but not cholesterol-lowering eﬀects of,
thyroid hormone derivatives [45]. Another possibility for
the multiplicity of responses is that the receptor is the same
but that it is present in diﬀerent cellular locations. For
example, it has been suggested by some that the nuclear
thyroid and steroid hormone receptors are also located in the
plasma membrane and mitochondria which could give rise
to diﬀerent actions with diﬀerent latency periods [40–42].
Recently, Cheng et al. [46] have claimed that the diﬀerent
responses to TH are initiated not only in the nucleus, but
also in the plasma membrane, cytoplasm, and mitochondria
(model 2). But ﬁrm evidence that these diﬀerent locations
represent distinct functional receptor entities such that each
would be responsible for a distinct response to the hormone
is however lacking.
The establishment of two distinct receptors for thyroid
hormone, TRα and TRβ, has allowed the separation of
diﬀerent actions of TH at the receptor level. It has also meant
that a well-characterized human thyroid disorder (thyroid
hormone resistance) could be explained on the basis of a
mutation in one and not the other TR isoform ([43, 47];
see Refetoﬀ, this issue). For some other hormones or cellular
signals, it is also possible to explain diﬀerent responses to
the same hormone on the basis of interactions with distinct
receptors. For example, the actions of oestrogen via ERα and
ERβ (oestrogen receptors α and β) explain the multiplicity of
theirbiologicalactionsasresultingfromaninitialinteraction
with distinct receptors in diﬀerent cell types. This possibility
is conﬁrmed by the identiﬁcation of oestrogen receptors α
and β present in the diﬀerent cell types but in the same
intracellular location, that is, the nucleus [48].
Another possible model suggests that the multiplicity of
action is a reﬂection of separate postreceptor downstream
chains of responses (model 3), but, again, no convincing
experimental evidence has been provided. One can invoke
other models, such as a modiﬁcation of that shown in
model 3, whereby the action of one hormone acting through
one receptor is qualitatively or quantitatively modulated by
the downstream action via responses to another receptor
(known or unknown) located in a diﬀerent part of the target
cell. The downstream modiﬁcations of responses could be
compared to how Brivanlou and Darnell [49]c o n c e p t u a l i z e
signals generated from the cell membrane can modify the
chain of responses to a signal generated from within the
cell, such as from the cell nucleus. The second (or third)
signal involved in cross-regulation need not be hormonal
in all cases and can be a growth factor, vitamin, antibody,
and so forth. Scanning the literature on hormone action in
general, many examples can be found whereby one or more
hormones can modify the action of another, irrespective
of whether or not these hormones act through nuclear or
membrane receptors. This is depicted in model 3 of Figure 3
in which hormones H2 and H3 modify the response to T3,Journal of Thyroid Research 9
Model
(1)
(2)
(3)
Black box
Hormone Receptor Responses
T3 TR T3-TR A
X
Y
Z
T3
TR T3-TR A X
Y
Z
R2 T3-R2 B
R3 T3-R3 C
H2 R2 H2-R2 B Y
X1
Z
X2
X3
T3 TR T3-TR A
H3 R3 H3-R3 C
Figure 3: Three hypothetical models for thyroid hormone action depicting permutations of multiple hormonal interplay at the postreceptor
level, represented by “Black Boxes” A, B, and C. According to model 1, the simplest situation is that T3 interacting with a single thyroid
hormone receptor (TR) modiﬁes the activity of a key postreceptor complex which gives rise to a chain of multiple responses X,Y,Z.T h e
multiplicity of responses to a hormone may also arise from diﬀerent chemical or structural isoforms of a single receptor, represented in
model 2 as TR, R2 and R3 together giving rise to multiple actions through functionally diﬀerent Black Boxes. Alternatively, the same single
receptor is present in diﬀerent cellular locations and behaves eﬀectively as diﬀerent receptors (TR, R2,R 3) in the same or diﬀerent cells. In
model 3, the multiplicity is a function of another hormone or signal (H2,H 3), acting via diﬀerent receptors (R2,R 3) to modify the nature,
multiplicity, or extent of the action(s) of T3, either before or after the action at the level of Black Boxes. The multiplicity, can also result from
further downstream interactions of the postreceptor responses (e.g., X1,X2,a n dX3).
e a c ha c t i n gt h r o u g hi t so w nr e c e p t o r .S o m ee x a m p l e so f
hormonal cross-regulation can be found in a most recent
review [50].
In all three models depicted in Figure 3, the crucial
element is the Black Box. Whereas there has been consid-
erable progress, especially since the molecular cloning of
hormonal and nonhormonal receptors, in understanding
the ﬁne details of receptor structure, function, and their
intermolecular complexes, it has not yet been possible so far
to link these data to the ﬁnal physiological action of a given
hormone.Itisthisgapinourknowledgeofreceptorfunction
and its relevance to the ﬁnal physiological action of the
hormone (in this case thyroid hormone) that is represented
bytheBlackBoxesinFigure 3.TheB lac kBo xc ouldbeao ne-
stepormultistepevent,thelattermostlikelyifrecentideasof
convergence of signals, networking, or proteomics turn out
to be the crucial elements for furthering our understanding
of mechanisms of hormone action. It represents a major
challenge currently to fully understanding the mechanism of
hormone action, in contrast to an enormous cataloguing of
the eﬀects produced by hormones in order to explain the
multiplicity of hormone action. An understanding of the
immediate postreceptor response by the target cell to the
hormonal signal is essential to enhance our understanding
of how hormonal signals accomplish their physiological
actions.10 Journal of Thyroid Research
7.A r eW eA n ywh e r eN earDisc o v e ringth e
“Mechanism”ofActionofThyroidHormone?
A central issue concerning hormone action has been to
understand the nature and function of hormone recep-
tors. The application at the end of the 20th century
of established and newly emerging technologies of gene
cloning, cell transfection, transgenesis and gene knock-out,
X-ray crystallography, and NMR analysis of DNA-protein
and protein-protein interactions have signiﬁcantly advanced
our understanding of the structure and function of both
membrane and nuclear hormone receptors. These advances
also point to the important position of cellular homologues
of oncogenes in the evolution of cell signalling mechanisms.
As regards thyroid hormone, what is most striking from
Table 3 is that our views on the mechanism of its action have
simply followed the progression of technology needed to
understand biological processes in ever more detail. Thus, to
answerthemainquestionposedinthisreviewaboutwhether
we are any closer to ﬁnding the ultimate mechanism of the
action of thyroid hormone, the answer has to be a qualiﬁed
“No.”Qualiﬁed,becausetheprogressioninoursearchforthe
mechanism of action of any hormone has been a function
of availability of new biochemical, biophysical, genetic, and
structural biological technologies. Often, this has simply
resulted in the cataloguing of an ever-rapidly accumulation
of eﬀects of hormones, but not of their mechanism of action.
In other words, the search for the mechanism of hormone
action is often largely technology driven and not suﬃciently
hypothesis based.
So, should one abandon the search for a molecular
mechanism of action of thyroid or any other hormone?
The answer again is “No.” On the contrary, attempts so far
to discover the mechanism of hormone action have often
led to the discovery of some fundamental principles of
biologicalregulationandsignalling.Forexample,Sutherland
and Rall’s search for the mechanism underlying how insulin
and glucagon regulate metabolic activity in rodent liver [14]
led them to discover cyclic AMP which, in turn, unearthed
a central pillar of regulatory biology of all living organisms,
equally applicable to bacteria, plants, and animals, and not
just restricted to hormone action. It was then a relatively
short step towards establishing the importance of protein
phosphorylation and dephosphorylation in so many vital
cellular functions [51], such as energy metabolism, protein
and DNA synthesis, and membrane receptor-linked activi-
ties, not to mention the subsequent discovery of cyclic GMP
and G-proteins, as vital signalling components within cell
membranes. Not less important, eﬀorts to unravel the role
of thyroid hormone in regulating transcription within the
cell nucleus have provided much valuable insight into the
multiplicity and functions of RNA polymerases [30]a n d
the importance of structural organisation of chromatin in
regulation of gene expression [8, 16].
8.Perspective
In the 1920s, the increasing availability of pure, nonde-
natured and biologically active proteins, along with the
advances in biochemistry of enzymes, soon led to explana-
tions of mechanisms of thyroid hormone action based on
hormone-enzymeinteraction.Later,thedevelopmentsofthe
methods for subcellular fractionation gave rise to hypotheses
based on hormones directly interacting with cell membrane
enzymes, mitochondria, ribosomes, and the cell nucleus to
explain regulation of energy metabolism, protein synthesis,
and transcriptional control. Hormone receptors, as cellular
homologues of oncogenes, now occupy a central position
in our current thinking of signalling mechanisms, whether
located in the cell membrane or the nucleus.
It is certain that increasingly rapid emergence of new
molecular, cellular, and physical technologies is going to lead
us to re-evaluate the validity and importance of our present-
day concepts of mechanisms of hormone action. One can
safely predict that, just as in the past, every new technical
advance is going to demand a rethinking, modiﬁcation,
or even rejection, of our currently accepted models and
introduce new concepts of how thyroid hormone elicits
its molecular mechanism of action. What are the most
likely developments in the future in our search for the
mechanismofthyroidhormoneaction?Thediscoveryofnew
factors associated with transcription, such as coactivators,
corepressors, and integrators, will continue to deﬁne in
greater detail how thyroid hormone receptors regulate gene
expression; many more modulators will be discovered in
the future and that these will be found to form even
more complex structures with nuclear hormone receptors
[16]. Similarly, it is only in the last decade that the true
signiﬁcance of enzymes that add or remove acetyl and
methyl groups in histones and other chromosomal proteins
has been realized in the context of a network of cellular
signals impinging on nuclear and extranuclear sites. As
yet we have uncovered the identity of only a fraction
of the approximately 300 chromatin-associated proteins.
The recent ﬁndings on histone modiﬁcations emphasize
nucleosome and chromatin structure as dynamic entities
that make up the transcriptional machinery and which, in
turn, is now leading us to a major shift in our thinking on
how thyroid (and steroid) hormones control gene expression
[8]. Indeed, Flamant and colleagues have more recently put
together a number of diﬀerent ways in which TH and TRs,
together and separately, render the mechanisms of signalling
by thyroid hormone much more complex than has been
thought of earlier [43].
In a wider perspective, there is an increasing realization
that the interaction between diﬀerent signalling mechanisms
operating through membrane, nuclear, and cytoplasmic sites
has to be considered as converging mechanisms, rather
than as individual or isolated pathways [49]. For example,
recently, Kress et al. [9]; (see Plateroti, this issue) have
emphasized the importance of considering crosstalk between
TH-controlled and other signalling mechanisms. The same
group have also highlighted another facet of TH action,
namely that the same signal can elicit dual and divergent
actions, in this case of cell proliferation and diﬀerentiation
and further propose that multiple gene networks will also
have to be taken into account [10]. They compare the
multiplicity of responses to the hormone with what has beenJournal of Thyroid Research 11
well known during amphibian metamorphosis where TH
can promote cell growth, diﬀerentiation, or cell death in
diﬀerent tissues of the larva [12]. More indirectly, factors
governingtheavailabilityofthyroidhormonetothereceptor,
or other sites in the pathway of its action, have also been
invoked. For example, the generation or inactivation of T3,
the active thyroid hormone, by iodothyronine deiodinases
has also to be considered as regulators of thyroid hormone
action in controlling metabolism and development [4, 52].
Clearly, much has yet to be learned about how thyroid
hormone signalling regulates speciﬁc gene expression and
diverse cellular functions from early development to cell
death. Finally, all future advances will have to be considered
in the context of evolutionary aspects of hormones and
their actions, while not losing sight of the history of earlier
attempts to explain the mechanism of hormone action.
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